Clinical Trial Pathology Services for Sponsors
Accurate tissue interpretation is critical to therapeutic validation. Microverse Research provides centralized histopathology review, cytopathology analysis, and pathology endpoint strategy designed to reduce variability across multi-site trials and strengthen the scientific defensibility of your data.
We collaborate directly with sponsors, CROs, and translational research teams to integrate pathology seamlessly into development programs from Phase I through Phase III studies.
Translational & Biomarker Integration
Our team supports tissue-based biomarker validation, correlative pathology analysis, and companion diagnostic alignment. By integrating anatomic pathology expertise early in development, we help mitigate risk, refine inclusion criteria, and improve endpoint clarity.
Regulatory & Quality-Focused Oversight
All services are directed by Board-Certified Pathologists and aligned with GCP, CLIA, CAP, and applicable regulatory standards. We deliver structured, audit-ready documentation that supports regulatory submissions and inspection preparedness.
Commitment to Excellence
At Microverse Research, we recognize that pathology plays a critical role in clinical validation and therapeutic advancement. We are committed to delivering decisive, high-integrity analysis that strengthens data credibility and supports successful clinical research outcomes.